GCC
TMO icon

Guardian Capital (Canada)’s Thermo Fisher Scientific TMO Stock Holding History

Guardian Capital (Canada)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Hold
2,432
– – 0.03% 139
2026
Q1 		$1.2M Hold
2,432
– – 0.03% 139
2025
Q4 		$1.41M Buy
+2,432
New +$1.38M 0.04% 127
2024
Q2 		– Sell
-3,198
Closed -$1.86M – 152
2024
Q1 		$1.86M Hold
3,198
– – 0.06% 109
2023
Q4 		$1.7M Sell
3,198
-264
-8% -$128K 0.06% 107
2023
Q3 		$1.75M Sell
3,462
-1,444
-29% -$769K 0.07% 102
2023
Q2 		$2.56M Sell
4,906
-3,768
-43% -$2.03M 0.08% 93
2023
Q1 		$5M Sell
8,674
-750
-8% -$423K 0.16% 81
2022
Q4 		$5.19M Sell
9,424
-192
-2% -$102K 0.17% 82
2022
Q3 		$4.88M Buy
9,616
+692
+8% +$387K 0.17% 81
2022
Q2 		$4.85M Buy
8,924
+844
+10% +$465K 0.15% 84
2022
Q1 		$4.77M Buy
8,080
+600
+8% +$345K 0.09% 89
2021
Q4 		$4.99M Buy
7,480
+125
+2% +$78K 0.1% 87
2021
Q3 		$4.2M Hold
7,355
– – 0.09% 89
2021
Q2 		$3.71M Buy
7,355
+630
+9% +$297K 0.07% 93
2021
Q1 		$3.07M Buy
6,725
+410
+6% +$196K 0.05% 92
2020
Q4 		$2.94M Buy
6,315
+145
+2% +$68K 0.07% 86
2020
Q3 		$2.72M Sell
6,170
-95
-2% -$39.2K 0.07% 84
2020
Q2 		$2.27M Buy
6,265
+1,990
+47% +$667K 0.06% 81
2020
Q1 		$1.21M Buy
4,275
+175
+4% +$55.2K 0.04% 92
2019
Q4 		$1.33M Buy
4,100
+235
+6% +$71.3K 0.03% 103
2019
Q3 		$1.13M Buy
3,865
+215
+6% +$61.6K 0.02% 106
2019
Q2 		$1.07M Buy
3,650
+1,580
+76% +$435K 0.02% 108
2019
Q1 		$567K Buy
+2,070
New +$515K 0.01% 127
2014
Q2 		– Sell
-2,545
Closed -$306K – 218
2014
Q1 		$306K Buy
+2,545
New +$303K ﹤0.01% 190
2013
Q4 		– Sell
-21,860
Closed -$2.01M – 215
2013
Q3 		$2.01M Sell
21,860
-320
-1% -$28.9K 0.03% 117
2013
Q2 		$1.88M Buy
+22,180
New +$1.85M 0.03% 111

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Guardian Capital (Canada)'s TMO Position: Q2 2026 in Review

Guardian Capital (Canada) held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2,432 shares worth $1.22M. The position accounts for 0.03% of the portfolio, ranked #139.

Guardian Capital (Canada) first reported a position in TMO in Q2 2013 and has held it in 27 quarters since. The position peaked at $5.19M in Q4 2022. 2,629 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Guardian Capital (Canada) held 2,432 shares of Thermo Fisher Scientific worth $1.22M as of Q2 2026.
  • Guardian Capital (Canada) left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.03% of Guardian Capital (Canada)'s portfolio in Q2 2026, its #139 holding.
  • Guardian Capital (Canada) first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 27 quarters since.
  • Guardian Capital (Canada)'s Thermo Fisher Scientific position peaked at $5.19M in Q4 2022.
  • 2,629 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.